Fogarty International Center

Fogarty International Center

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Funding Opportunities NIH funding opportunities focusing on global health and foreign collaboration, and related news. Notice of Intent to Publish Funding Opportunity Announcements for Phase 2 of the U.S.-South Africa Program for Collaborative Biomedical Research (R01 and U01, Clinical Trial Optional) (NOT-AI-19-032) The intent of the U.S.-South Africa Program for Collaborative Biomedical Research is to foster, stimulate, and/or expand basic, translational, behavioral and applied research that will advance scientific discovery and engage U.S. and South African researchers working collaboratively in the areas of HIV/AIDS, HIV/AIDS-associated malignancies, and other infectious diseases. These funding announcements are expected to be published in March 2019 with an expected application due date in July 2019. About phase 1: NIH, South Africa partner on $8M in research projects May/Jun 2015 Global Health Matters newsletter Phase 1 awards from NIAID: US-South Africa awarded phase 1 grants Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) (PAR-19-149) and (R21 Clinical Trial Optional) (PAR-19-150) Application Receipt/Submission Date(s): Standard dates apply Note: This announcement aims to support first steps toward delivery of new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and/or medical care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating NIH Institutes and Centers. Notice of Letter of Intent Guidance for PAR-19-098 Emerging Global Leader Award (K43; Independent Clinical Trial Not Allowed) and PAR-19-051 Emerging Global Leader Award (K43; Independent Clinical Trial Required) (NOT-TW-19-001) More about Fogarty’s Emerging Global Leader Award. NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply. Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed) (PAR-19-156) and (U01 Clinical Trial Required) (PAR-19-157) Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) (PAR-19-158) and (R01 Clinical Trial Required) (PAR-19-159) Application Receipt/Submission Date(s): Standard dates apply The National Cancer Institute’s Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trials Required) (RFA-CA-19-007) Application Receipt Date(s): May 22,2019 Technologies for Basic and Clinical Cancer Research: Innovative Molecular and Cellular Analysis (R21 Clinical Trials Not Allowed) (RFA-CA-19-019) Advanced Development and Validation of Emerging Molecular and Cellular Analysis (R33 Clinical Trials Not Allowed) (RFA-CA-19-020) Innovative Biospecimen Science (R21 Clinical Trials Not Allowed) (RFA-CA-19-021) Advanced Development and Validation of Emerging Biospecimen Science (R33 Clinical Trials Not Allowed) (RFA-CA-19-022) Application Receipt Date(s): March 7, 2019; May 28, 2019; September 27, 2019 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) (RFA-CA-19-023) and (U01 Clinical Trial Optional) (RFA-CA-19-024) Application Receipt Date(s): March 7, 2019; May 28, 2019; September 27, 2019 Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required) (RFA-CA-19-033) Application Receipt Date(s): March 15, 2019; January 3, 2020 Related Notice: Pre-Application Webinar [on Thursday, January 31, 2019] for RFA-CA-19-033, Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required) (NOT-CA-19-020) End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) (PAR-19-153) Application Receipt/Submission Date(s): Standard dates apply National Institute of Dental and Craniofacial Research (NIDCR) Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed) (PAR-19-145) Application Receipt/Submission Date(s): Standard dates apply Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed) (PAR-19-146) and (R01 Clinical Trials Not Allowed) (PAR-19-147) Application Receipt/Submission Date(s): Standard dates apply Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) (PAR-19-162) and (R21-Clinical Trial Not Allowed) (PAR-19-163) Application Receipt/Submission Date(s): Standard dates apply NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity. Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R43/R44 Clinical Trial Optional) (RFA-DA-19-021) and (R41/R42 Clinical Trial Optional) (RFA-DA-19-022) Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/R42 - Clinical Trial Optional) (RFA-DA-19-032) and (R43/R44 - Clinical Trial Optional) (RFA-DA-19-033) Application Receipt Date(s): March 19, 2019

Funding News

NIH funding news that may be relevant to global health researchers.

• Removal of the Requirement for Institutional Review Board Review of NIH Grant Applications and Contract Proposals Related to Research (NOT-OD-19-055)
• NIH Policy for Review and Resubmission of New Investigator R01 Applications (NOT-OD-19-053)
• Notice of Clarification Regarding Harassment and Discrimination Protections in NIH Training Applications (NOT-OD-19-056)
• Request for Information (RFI): Inviting Comments on the NIDA Strategic plan for Research at the Intersection of HIV/AIDS and Substance Use, Misuse and Addiction (NOT-DA-19-015)
• Notice of Information: Updates and clarifications of several components of the [Antimicrobial Resistance Rapid, Point-of-Need Diagnostic Test] Challenge competition posted within the Federal Register (NOT-OD-19-046)
• Notice of Special Interest in Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development (NOT-DK-19-007)
• Notice of NIMHD's Interest in Research on Disability in Health Disparity Populations (NOT-MD-19-007)
• Notice of Participation of the National Institute on Minority Health and Health Disparities (NIMHD) in Research on Current Topics in Alzheimers Disease and its Related Dementias PAR-19-070, (R01 Clinical Trial Optional) (NOT-MD-19-016) and PAR-19-071 (R21 Clinical Trial Not Allowed) (NOT-MD-19-017)
• AHRQ Announces Change in Grant Recipient Purchasing of Identifiable CMS Data, effective FY2019 (NOT-HS-19-007)
• Register to Attend the NIH Regional Seminar on Program Funding and Grants Administration Baltimore, MD May 2019 (NOT-OD-19-058)

Upcoming Deadlines

• International Research Scientist Development Award (IRSDA)
  Application deadline: March 7, 2019
• Planning for Noncommunicable Diseases and Disorders Research Training
  Application deadline: March 14, 2019
• Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for U.S. Researchers in Japan
  Application deadline: March 15, 2019
• Global Infectious Disease Research Training Program
  Application deadline: July 25, 2019